There is a large number of studies that demonstrates a complicated association between gut microbiota and cancer, including recent compelling evidence suggesting the role of gut microbiota-commensal Bifidobacterium in promoting antitumor immunity and facilitating anti-programmed death ligand 1 (PD-L1) efficacy, thus modulating cancer immunotherapy [211]. Here, CD274 is linked to cancer.